Data as of Dec 06
| +0.01 / +0.52%|
The 3 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 3.00. The median estimate represents a +105.13% increase from the last price of 1.95.
The current consensus among 5 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.